Icosapent Ethyl Capsule
Product Images NDC 71335-2989

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Icosapent Ethyl (NDC 71335-2989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tab 2 (Table 2)

This is a comparison of the effects of Cosapent Ethyl 4g/day versus Placebo on various lipid parameters such as TG, LDL-C, Non-HDL-C, TC, HDL-C, VLDL-C, and Apo B. The table shows the baseline values, percentage changes, and confidence intervals for each parameter measured in a study with N=76 for Cosapent Ethyl and N=75 for Placebo. The results suggest that Cosapent Ethyl led to improvements in TG, LDL-C, Non-HDL-C, TC, and VLDL-C compared to Placebo, as indicated by the negative percentage changes and lower values within the confidence intervals.*

FDA Label Image

Label (Lbl713352989)

Each capsule contains 1 gram of Icosapent. The recommended adult dosage can be found in the package insert. Pharmacists are instructed to dispense the medication ethyl capsules with a guide for each patient. The medication should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It should be kept in a tight, light-resistant container and out of reach of children.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.